The World Health Organization (WHO) has justified its call to stop introducing booster doses of COVID-19 vaccines as the gap widens between rich countries with broad access to COVID-19 vaccines and poor countries where they are not common.

– We have to reverse this trend. Most of the vaccines that go to rich countries should go to the poor, said WHO Director-General Tedros Adhanom Ghebreyesus, at a press conference in Geneva, where the organization is based.

The WHO’s reaction was triggered by reports from Germany and Israel, where vaccination campaigns with the third dose of COVID-19 preparations have already begun. Booster doses are primarily for older adults whose immune system does not produce sufficient antibodies despite being fully vaccinated with two doses of SARS-CoV-2 immunization.

delta variable. The third dose of Pfizer increases the number of antibodies fivefold

According to the head of the World Health Organization, the global moratorium on steroids should be in place “at least until the end of September”. This would help in trying to achieve 10% of global vaccination. Population of every country in the world.

Of the 4 billion doses applied in the world to date, 80 percent. These have been reported in high-income or upper-middle-income countries, which account for only half of the world’s population.

The United States rejected a call for comment on the same day, saying there was “no need” to choose between giving a third dose of the vaccine to its citizens or donating to poor countries. However, the USA has not yet made an administrative decision regarding the application of the third dose of COVID-19.

See also  President Duda was at the harvest festival and had already left Poland. You won't guess where! - Super Express

In addition to calling for the WHO’s suspension, at Wednesday’s press conference, it called on pharmaceutical companies that produce vaccines against COVID-19 to consider pricing. As their products are adapted to the new variants of SARS-CoV-2, Pfizer and Moderna intend to increase the prices of preparations sold in the European Union.